Clinical trial
A Proof-of-Concept Phase 2, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-201 for the Treatment of A Single Tension-Type Headache
NCT02423408 is registered in ClinicalTrials.gov with Tonix Pharmaceuticals, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Proof-of-Concept Phase 2, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-201 for the Treatment of A Single Tension-Type Headache
- Lead sponsor
- Tonix Pharmaceuticals, Inc.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- June 30, 2015
- Completion date
- February 29, 2016
- Enrollment
- 165 (actual)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.